Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
Lucas
B A
BA
Department of Surgery, University of Kentucky Medical Center, Lexington 40536.
Waid
T H
TH
Thompson
J S
JS
Brown
S A
SA
Munch
L C
LC
McKeown
J W
JW
Kryscio
R J
RJ
Prebeck
R J
RJ
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000917:Antibody Formation; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection / Q000628:therapy*; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D016019:Survival Analysis; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D003404:Creatinine